Santa Fe Partners’s Impax Laboratories, Inc. IPXL Stock Holding History

Santa Fe Partners’s Portfolio IPXL Stock Details IPXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-10,499	Closed	-$449K	–	387
2015 Q4	$449K	Buy	+10,499	New	+$419K	0.07%	356
2015 Q3	–	Sell	-4,738	Closed	-$217K	–	635
2015 Q2	$217K	Buy	+4,738	New	+$225K	0.03%	451
2014 Q2	–	Sell	-26,608	Closed	-$703K	–	633
2014 Q1	$703K	Buy	+26,608	New	+$665K	0.1%	308

Other funds holding IPXL

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Hound Partners New York $799M AUM 9.54% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Aravt Global New York $11.3M AUM 3.78% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

PCM

Pennant Capital Management Summit, New Jersey $212M AUM 19.37% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Santa Fe Partners's IPXL Position: Q1 2016 in Review

Santa Fe Partners sold out of Impax Laboratories, Inc. (IPXL) in Q1 2016, closing a stake of 10,499 shares — an estimated $449K sold.

Santa Fe Partners first reported a position in IPXL in Q1 2014 and held it in 3 quarters. The position peaked at $703K in Q1 2014. 194 funds tracked by Wall St. Rank hold IPXL as of Q1 2016.

Santa Fe Partners reported no remaining Impax Laboratories, Inc. position as of Q1 2016 after selling out during the quarter.
Santa Fe Partners sold 10,499 Impax Laboratories, Inc. shares in Q1 2016, an estimated $449K.
Santa Fe Partners first reported a position in Impax Laboratories, Inc. in Q1 2014 and held it in 3 quarters.
Santa Fe Partners's Impax Laboratories, Inc. position peaked at $703K in Q1 2014.
194 funds tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q1 2016.

Based on Santa Fe Partners's 13F filing for Q1 2016.